In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action

/PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that it will hold an in-person and virtual...

Related Keywords

Stockholm ,Sweden ,United States ,Leicester ,United Kingdom ,American ,Jonathan Barratt ,Garethj Thomas ,Gareth Thomas ,American Society Of Nephrology Kidney Health Initiative ,University Of Leicester ,Iga Nephropathy Network ,Renal Research Group ,Phd University Hospital Southampton ,University Of Southampton ,Life Sciences ,Rare Disease Group ,Inderes Event Studio ,University Hospital Southampton ,Experimental Pathology ,United Kingdom National Registry ,Rare Kidney Diseases ,In Ternational Iga Nephropathy ,Chief Investigator ,American Society ,Nephrology Kidney Health Initiative ,Identifying Surrogate Endpoints ,Clinical Trials ,Iga Nephropathy Work ,Calliditas Therapeutics ,